CLSI MM17 P : 1ED 2007

Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
   4.1 Definitions
   4.2 Acronyms/Abbreviations
5 Sample Preparation
   5.1 Sample Types
   5.2 Manual Nucleic Acid Extraction
   5.3 Integrity
   5.4 Purity
   5.5 Automated Nucleic Acid Extraction
6 Target Amplification Technologies
   6.1 Target Amplification Technologies
   6.2 Particle-Based Signal Detection Technologies
   6.3 Signal Amplification Technologies
   6.4 Bioelectronic Array Detection of DNA and RNA Hybrids
   6.5 Addressable Microarray
   6.6 Microfluidic Cards
7 Reference and Testing Materials
   7.1 Endogenous Nucleic Acid
   7.2 WGA
   7.3 Nongenomic RMs
   7.4 Internal Controls
8 Analytic Verification and Validation
   8.1 Characterization and Presence of Reagent Components
   8.2 Technical Standard Operating Procedure (TSOP)
   8.3 Software and Algorithms
   8.4 Analytic Validation.
   8.5 Analytic Validation of an LDA
   8.6 Analytic Verification of an IVD
9 Data Analysis and Reporting of Results
   9.1 Types of Tests and Concomitant Data Requirements
   9.2 Genotype Calls
   9.3 Analysis of Analytical Study Results
   9.4 Analysis of Clinical Study Results
   9.5 Possible Limitations
10 Concluding Remarks
References
Additional References and Resources
The Quality Management System Approach
Related CLSI/NCCLS Publications